Merus Labs International (Merus Labs International) Cash-to-Debt : 0.01 (As of Mar. 2017)

View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Merus Labs International's cash to debt ratio for the quarter that ended in Mar. 2017 was 0.01.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Merus Labs International couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2017.

The historical rank and industry rank for Merus Labs International's Cash-to-Debt or its related term are showing as below:

MSLI's Cash-to-Debt is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.945
* Ranked among companies with meaningful Cash-to-Debt only.

Merus Labs International Cash-to-Debt Historical Data

The historical data trend for Merus Labs International's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Merus Labs International Cash-to-Debt Chart

Merus Labs International Annual Data

Trend

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Cash-to-Debt

Get a 7-Day Free Trial

0.09

0.22

0.18

0.65

0.02

Merus Labs International Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Cash-to-Debt	Get a 7-Day Free Trial															0.06	0.03	0.02	0.03	0.01

Competitive Comparison of Merus Labs International's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Merus Labs International's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merus Labs International's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merus Labs International's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Merus Labs International's Cash-to-Debt falls into.

Merus Labs International Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Merus Labs International's Cash to Debt Ratio for the fiscal year that ended in Sep. 2016 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.454	/	(31.332	+	83.151)
	=	0.02

Merus Labs International's Cash to Debt Ratio for the quarter that ended in Mar. 2017 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.979	/	(31.549	+	70.013)
	=	0.01

Merus Labs International (NAS:MSLI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Merus Labs International Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Merus Labs International (Merus Labs International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.meruslabs.com

Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines

From GuruFocus

Merus Labs International: A Pharma Stock With Growth Potential

By Gordon Pape Gordon Pape • 03-30-2015

Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems, Athabasca Minerals

By Gordon Pape Gordon Pape • 10-05-2015

Update on Merus Labs International, Athabasca Minerals Inc, Enghouse Systems Limited, WiLAN Inc.

By Gordon Pape Gordon Pape • 06-22-2015